Candel Therapeutics, Inc.
USD10.36
+0.57 (+5.82%)
CEO
Paul-Peter Tak
IPO Date
2021-07-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.88
Prev. Close
$9.79
Day Low
$9.80
Day High
$10.38
52W Low
$4.35
52W High
$10.38
Market Cap
$0.57B
Volume
1.47M
| 32,000 |
| $9.08 |
| 24 Jun 2026 | PAPA JOSEPH C | director | A-Award | Acquired | 32,000 | $9.08 |
| 24 Jun 2026 | Benz Edward J. JR | director | A-Award | Acquired | 32,000 | $9.08 |
| 24 Jun 2026 | Martell Christopher | director | A-Award | Acquired | 32,000 | $9.08 |
| 24 Jun 2026 | Gaeta Renee | director | A-Award | Acquired | 32,000 | $9.08 |
| 24 Jun 2026 | Nabel Gary J. | director | A-Award | Acquired | 32,000 | $9.08 |
| 24 Jun 2026 | Nguyen Diem | director | A-Award | Acquired | 32,000 | $9.08 |
| 24 Jun 2026 | Manning Paul B | director | A-Award | Acquired | 32,000 | $9.08 |
| 2 Apr 2026 | Manning Paul B | director | A-Award | Acquired | 4,618 | $4.90 |